Dynamic DNA methylation of matrix metalloproteinase-9 in the development of diabetic retinopathy

Laboratory Investigation

Volumn 96, Issue 10, 2016, Pages 1040-1049

  Kowluru, Renu A ^a   Shan, Yang ^a   Mishra, Manish ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYMETHYL CYTOSINE; 5 METHYLCYTOSINE; CYTOSINE DERIVATIVE; DNA METHYLTRANSFERASE 1; GELATINASE B; GLUCOSE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DIABETIC RETINOPATHY; DNA METHYLATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; IN VITRO STUDY; LIMIT OF QUANTITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RETINA BLOOD VESSEL; TRANSCRIPTION INITIATION; ANIMAL; BOVINE; C57BL MOUSE; CELL CULTURE; COMPLICATION; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; RANDOMIZATION; RETINA;

ANIMALS; CATTLE; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; DNA METHYLATION; ENDOTHELIAL CELLS; MATRIX METALLOPROTEINASE 9; MICE, INBRED C57BL; RANDOM ALLOCATION; RETINA; RNA, SMALL INTERFERING;

EID: 84988622288     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2016.78     Document Type: Article

References (45)

1. Kowluru RA, Abbas SN. Diabetes-induced mitochondrial dysfunction in the retina. Invest Ophthalmol Vis Sci 2003;44:5327-5334.
2. Kanwar M, Chan PS, Kern TS, et al. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest Ophthalmol Vis Sci 2007;48:3805-3811.
3. Kowluru RA, Kowluru A, Mishra M, et al. Oxidative stress and epigenetic modifications in the pathogenesis of diabetic retinopathy. Prog Retin Eye Res 2015;48:40-61.
4. Kowluru RA, Mohammad G, dos Santos JM, et al. Abrogation of MMP-9 gene protects against the development of retinopathy in diabetic mice by preventing mitochondrial damage. Diabetes 2011;60:3023-3033.
5. Santos JM, Tewari S, Lin JY, et al. Interrelationship between activation of matrix metalloproteinases and mitochondrial dysfunction in the development of diabetic retinopathy. Biochem Biophys Res Commun 2013;438:760-764.
6. Kowluru RA, Santos JM, Zhong Q. Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy. Invest Ophthalmol Vis Sci 2014;55:5653-5660.
7. Kern TS, Tang J, Mizutani M, et al. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci 2000;41: 3972-3978.
8. Hsieh MJ, Lin CW, Yang SF, et al. Glabridin inhibits migration and invasion by transcriptional inhibition of matrix metalloproteinase 9 through modulation of NF-kB and AP-1 activity in human liver cancer cells. Br J Pharmacol 2014;171:3037-3050.
9. Zhong Q, Kowluru RA. Regulation of matrix metalloproteinase-9 by epigenetic modifications and the development of diabetic retinopathy. Diabetes 2013;62:2559-2568.
10. Ling C, Groop L. Epigenetics: a molecular link between environmental factors and type 2 diabetes. Diabetes 2009;58:2718-2725.
11. Villeneuve LM, Reddy MA, Natarajan R. Epigenetics: deciphering its role in diabetes and its chronic complications. Clin Exp Pharmacol Physiol 2011;38:401-409.
12. Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 2012;13:484-492.
13. Robertson KD, Wolffe AP. DNA methylation in health and disease. Nat Rev Genet 2000;1:11-19.
14. Nasonkin IO, Lazo K, Hambright D, et al. Distinct nuclear localization patterns of DNA methyltransferases in developing and mature mammalian retina. J Comp Neurol 2011;519:1914-1930.
15. Wahlin KJ, Enke RA, Fuller JA, et al. Epigenetics and cell death: DNA hypermethylation in programmed retinal cell death. PLoS One 2013;8: e79140.
16. Yan B, Yao J, Tao ZF, et al. Epigenetics and ocular diseases: from basic biology to clinical study. J Cell Physiol 2013;229:825-833.
17. Kowluru RA, Santos JM, Mishra M. Epigenetic modifications and diabetic retinopathy. Biomed Res Int 2013;2013:635284.
18. He S, Li X, Chan N, et al. Review: epigenetic mechanisms in ocular disease. Mol Vis 2013;19:665-674.
19. Tewari S, Zhong Q, Santos JM, et al. Mitochondria DNA replication and DNA methylation in the metabolic memory associated with continued progression of diabetic retinopathy. Invest Ophthalmol Vis Sci 2012;53: 4881-4888.
20. Mishra M, Kowluru RA. Epigenetic modification of mitochondrial DNA in the development of diabetic retinopathy. Invest Ophthalmol Vis Sci 2015;56:5133-5142.
21. Guibert S, Forne T, Weber M. Dynamic regulation of DNA methylation during mammalian development. Epigenomics 2009;1: 81-98.
22. Majumdar S, Buckles E, Estrada J, et al. Aberrant DNA methylation and prostate cancer. Curr Genomics 2011;12:486-505.
23. Tahiliani M, Koh KP, Shen Y, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by mll partner tet1. Science 2009;324:930-935.
24. Kohli RM, Zhang Y. Tet enzymes, tdg and the dynamics of DNA demethylation. Nature 2013;502:472-479.
25. Wu H, Zhang Y. Reversing DNA methylation: mechanisms, genomics, and biological functions. Cell 2014;156:45-68.
26. Dhliwayo N, Sarras Jr MP, Luczkowski E, et al. PARP inhibition prevents ten-eleven translocase enzyme activation and hyperglycemia-induced DNA demethylation. Diabetes 2014;63:3069-3076.
27. Chicoine E, Esteve PO, Robledo O, et al. Evidence for the role of promoter methylation in the regulation of MMP-9 gene expression. Biochem Biophys Res Commun 2002;297:765-772.
28. Ling L, Ren M, Yang C, et al. Role of site-specific DNA demethylation in Tnf alpha-induced MMP-9 expression in keratinocytes. J Mol Endocrinol 2013;50:279-290.
29. Xu W, Yang H, Liu Y, et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Cancer Cell 2011;19:17-30.
30. Williams K, Christensen J, Pedersen MT, et al. Tet1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 2011;473:343-348.
31. Kern TS. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res 2007;2007:95103.
32. Kowluru RA. Mitochondria damage in the pathogenesis of diabetic retinopathy and in the metabolic memory associated with its continued progression. Curr Med Chem 2013;20:3226-3233.
33. Kowluru RA, Zhong Q, Santos JM. Matrix metalloproteinases in diabetic retinopathy: potential role of mmp-9. Expert Opin Investig Drugs 2012;21:797-805.
34. Mishra M, Flaga J, Kowluru RA. Molecular mechanism of transcriptional regulation of matrix metalloproteinase-9 in diabetic retinopathy. J Cell Physiol 2016;231:1709-1718.
35. Deaton AM, Bird A. Cpg islands and the regulation of transcription. Genes Dev 2011;25:1010-1022.
36. Pirola L, Balcerczyk A, Okabe J, et al. Epigenetic phenomena linked to diabetic complications. Nat Rev Endocrinol 2010;6:665-675.
37. Gemenetzi M, Lotery AJ. The role of epigenetics in age-related macular degeneration. Eye (Lond) 2014;28:1407-1417.
38. Kato M, Natarajan R. Diabetic nephropathy-emerging epigenetic mechanisms. Nat Rev Nephrol 2014;10:517-530.
39. Medvedeva YA, Fridman MV, Oparina NJ, et al. Intergenic, gene terminal, and intragenic cpg islands in the human genome. BMC Genomics. 2010;11:48.
40. Nan X, Ng HH, Johnson CA, et al. Transcriptional repression by the methyl-cpg-binding protein Mecp2 involves a histone deacetylase complex. Nature 1998;393:386-389.
41. Yang H, Liu Y, Bai F, et al. Tumor development is associated with decrease of tet gene expression and 5-methylcytosine hydroxylation. Oncogene 2013;32:663-669.
42. Wang J, Tang J, Lai M, et al. 5-Hydroxymethylcytosine and disease. Mutat Res Rev Mutat Res 2014;762:167-175.
43. Liu ZZ, Zhao XZ, Zhang XS, et al. Promoter DNA demethylation of keap1 gene in diabetic cardiomyopathy. Int J Clin Exp Pathol 2014;7: 8756-8762.
44. Li D, Guo B, Wu H, et al. Tet family of dioxygenases: crucial roles and underlying mechanisms. Cytogenet Genome Res 2015;146:171-180.
45. Olsen AS, Sarras MP, Leontovich A, et al. Heritable transmission of diabetic metabolic memory in zebrafish correlates with DNA hypomethylation and aberrant gene expression. Diabetes 2012;61: 485-491.